FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322763922> ?p ?o ?g. }

• W4322763922 endingPage "e33134" @default.
• W4322763922 startingPage "e33134" @default.
• W4322763922 abstract "Untreated chronic hyperkalemia is associated with an increased risk of mortality. Novel potassium binders (e.g., patiromer) are new additions to the clinician’s armamentarium. Prior to their approval, clinicians often considered trialing sodium polystyrene sulfonate. The study objective was to assess patiromer utilization and associated changes in serum potassium (K+) in US veterans with prior sodium polystyrene sulfonate exposure. This was a real-world observational study of US veterans with chronic kidney disease and a baseline K+ ≥ 5.1 mEq/L, initiated on patiromer between January 1, 2016, and February 28, 2021. The primary endpoints were patiromer utilization (dispensations and treatment courses), and K+ change at 30-, 91-, and 182-day follow-up (FU) intervals. Patiromer utilization was described using Kaplan–Meier probabilities and the proportion of days covered. Descriptive changes in population average K+ were obtained from a pre-post design using single-arm within-patient pre-post lab pairs and paired t tests. Two hundred five veterans met the study criteria. We observed an average of 1.25 (95% CI, 1.19–1.31) treatment courses and a median treatment duration of 64 days. Fifty veterans (24.4%) had >1 course, and 17.6% of patients remained on their initial patiromer treatment course until the end of the 180-day FU. The mean K+ value was 5.73 mEq/L (5.66–5.79) at baseline, 4.95 mEq/L (95% CI, 4.86–5.05) at the 30-day interval, 4.93 mEq/L (95% CI, 4.84–5.03) at the 91-day interval, and 4.9 mEq/L (95% CI, 4.8–4.99) at the 182-day interval. Novel potassium binders (e.g., patiromer) are newer chronic hyperkalemia management tools for clinicians. The average population K+ decreased to <5.1 mEq/L at all follow-up intervals. Patiromer appeared to be well tolerated with nearly 18% of patients remaining on their initial treatment course during the entire 180-day FU period. The median treatment duration was 64 days and approximately 24% of patients initiated a second course during FU." @default.
• W4322763922 created "2023-03-03" @default.
• W4322763922 creator A5013767189 @default.
• W4322763922 creator A5017541508 @default.
• W4322763922 creator A5027891031 @default.
• W4322763922 creator A5042411224 @default.
• W4322763922 creator A5045097402 @default.
• W4322763922 creator A5063546506 @default.
• W4322763922 creator A5074587712 @default.
• W4322763922 creator A5085301289 @default.
• W4322763922 creator A5086838101 @default.
• W4322763922 creator A5089363439 @default.
• W4322763922 date "2023-03-03" @default.
• W4322763922 modified "2023-09-26" @default.
• W4322763922 title "Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure" @default.
• W4322763922 cites W1756552807 @default.
• W4322763922 cites W1970939567 @default.
• W4322763922 cites W2154901533 @default.
• W4322763922 cites W2324948948 @default.
• W4322763922 cites W2761171944 @default.
• W4322763922 cites W2767867983 @default.
• W4322763922 cites W2768906675 @default.
• W4322763922 cites W2884647724 @default.
• W4322763922 cites W2972966903 @default.
• W4322763922 cites W2979523141 @default.
• W4322763922 cites W3003149826 @default.
• W4322763922 cites W3032629802 @default.
• W4322763922 cites W3047344708 @default.
• W4322763922 cites W3095770618 @default.
• W4322763922 cites W4288445068 @default.
• W4322763922 doi "https://doi.org/10.1097/md.0000000000033134" @default.
• W4322763922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36862858" @default.
• W4322763922 hasPublicationYear "2023" @default.
• W4322763922 type Work @default.
• W4322763922 citedByCount "0" @default.
• W4322763922 crossrefType "journal-article" @default.
• W4322763922 hasAuthorship W4322763922A5013767189 @default.
• W4322763922 hasAuthorship W4322763922A5017541508 @default.
• W4322763922 hasAuthorship W4322763922A5027891031 @default.
• W4322763922 hasAuthorship W4322763922A5042411224 @default.
• W4322763922 hasAuthorship W4322763922A5045097402 @default.
• W4322763922 hasAuthorship W4322763922A5063546506 @default.
• W4322763922 hasAuthorship W4322763922A5074587712 @default.
• W4322763922 hasAuthorship W4322763922A5085301289 @default.
• W4322763922 hasAuthorship W4322763922A5086838101 @default.
• W4322763922 hasAuthorship W4322763922A5089363439 @default.
• W4322763922 hasBestOaLocation W43227639221 @default.
• W4322763922 hasConcept C126322002 @default.
• W4322763922 hasConcept C167135981 @default.
• W4322763922 hasConcept C178790620 @default.
• W4322763922 hasConcept C185592680 @default.
• W4322763922 hasConcept C23131810 @default.
• W4322763922 hasConcept C2778653478 @default.
• W4322763922 hasConcept C2780243291 @default.
• W4322763922 hasConcept C2908647359 @default.
• W4322763922 hasConcept C44249647 @default.
• W4322763922 hasConcept C517785266 @default.
• W4322763922 hasConcept C71924100 @default.
• W4322763922 hasConcept C99454951 @default.
• W4322763922 hasConceptScore W4322763922C126322002 @default.
• W4322763922 hasConceptScore W4322763922C167135981 @default.
• W4322763922 hasConceptScore W4322763922C178790620 @default.
• W4322763922 hasConceptScore W4322763922C185592680 @default.
• W4322763922 hasConceptScore W4322763922C23131810 @default.
• W4322763922 hasConceptScore W4322763922C2778653478 @default.
• W4322763922 hasConceptScore W4322763922C2780243291 @default.
• W4322763922 hasConceptScore W4322763922C2908647359 @default.
• W4322763922 hasConceptScore W4322763922C44249647 @default.
• W4322763922 hasConceptScore W4322763922C517785266 @default.
• W4322763922 hasConceptScore W4322763922C71924100 @default.
• W4322763922 hasConceptScore W4322763922C99454951 @default.
• W4322763922 hasIssue "9" @default.
• W4322763922 hasLocation W43227639221 @default.
• W4322763922 hasLocation W43227639222 @default.
• W4322763922 hasLocation W43227639223 @default.
• W4322763922 hasLocation W43227639224 @default.
• W4322763922 hasOpenAccess W4322763922 @default.
• W4322763922 hasPrimaryLocation W43227639221 @default.
• W4322763922 hasRelatedWork W133937744 @default.
• W4322763922 hasRelatedWork W2049058840 @default.
• W4322763922 hasRelatedWork W2063784476 @default.
• W4322763922 hasRelatedWork W2474074509 @default.
• W4322763922 hasRelatedWork W2650906489 @default.
• W4322763922 hasRelatedWork W2760786034 @default.
• W4322763922 hasRelatedWork W3167292191 @default.
• W4322763922 hasRelatedWork W3212622766 @default.
• W4322763922 hasRelatedWork W4245370611 @default.
• W4322763922 hasRelatedWork W4327895846 @default.
• W4322763922 hasVolume "102" @default.
• W4322763922 isParatext "false" @default.
• W4322763922 isRetracted "false" @default.
• W4322763922 workType "article" @default.